Literature DB >> 8818969

A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV 16 and 18 in cervical scrapes after GP5+/6+ PCR.

M V Jacobs1, A J van den Brule, P J Snijders, T J Helmerhorst, C J Meijer, J M Walboomers.   

Abstract

In previous studies, general primer mediated PCR (GP5+/6+ PCR) was applied successfully to detect a broad spectrum of human papillomaviruses (HPV) in cervical scrapes. In order to facilitate PCR based HPV detection and typing, a colourimetric microtitre plate based hybridisation assay was developed. The method utilised one biotinylated primer (bio-GP6+) in the GP-PCR. Biotinylated PCR products were captured on streptavidin coated microtitre plates, denaturated and hybridised to digoxigenin (DIG) labelled HPV specific internal oligo probes. The DIG labelled hybrids were detected using an enzyme immunoassay (EIA). Since HPV 16 and 18 are the most common HPV types found in cervical carcinomas, this approach was initiated for these two types. Cross-hybridisation reactions were not detected when the specificity of this PCR-EIA for HPV 16 and 18 was tested on a panel of 20 different HPV genotypes. The sensitivity of the assay was found to be between 10 and 100 HPV 16 and 18 viral genomes in a background of 100 ng cellular DNA. This was similar to the detection limit of Southern blot analysis of PCR products with radioactively labelled oligonucleotides. A group of cytomorphologically normal (n = 89) and abnormal (n = 96) cervical scrapes were composed of HPV 16 and HPV 18 positive and HPV negative scrapes. All HPV 16 and 18 positive smears were detected by PCR-EIA. These results indicate that PCR-EIA has the potential for a rapid and sensitive HPV DNA test for day-to-day routine examination of cervical scrapes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818969     DOI: 10.1002/(SICI)1096-9071(199607)49:3<223::AID-JMV11>3.0.CO;2-D

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Distribution of 14 high risk HPV types in cervical intraepithelial neoplasia detected by a non-radioactive general primer PCR mediated enzyme immunoassay.

Authors:  I Nindl; B Lotz; R Kühne-Heid; U Endisch; A Schneider
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

2.  A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.

Authors:  M V Jacobs; P J Snijders; A J van den Brule; T J Helmerhorst; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Detecting every genital papilloma virus infection: what does it mean?

Authors:  C P Crum
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

4.  Comparison of three commercially available peptide-based immunoglobulin G (IgG) and IgA assays to microimmunofluorescence assay for detection of Chlamydia trachomatis antibodies.

Authors:  Servaas A Morré; Christian Munk; Kenneth Persson; Susanne Krüger-Kjaer; Rogier van Dijk; Chris J L M Meijer; Adriaan J C van Den Brule
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Monitoring of epstein-barr virus DNA load in peripheral blood by quantitative competitive PCR.

Authors:  S J Stevens; M B Vervoort; A J van den Brule; P L Meenhorst; C J Meijer; J M Middeldorp
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

6.  Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. The Canadian Women's HIV study group.

Authors:  F Coutlée; P Gravitt; H Richardson; C Hankins; E Franco; N Lapointe; H Voyer
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

7.  Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis.

Authors:  S Youshya; K Purdie; J Breuer; C Proby; M T Sheaf; R T D Oliver; S Baithun
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

8.  Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison.

Authors:  M V Jacobs; P J Snijders; F J Voorhorst; J Dillner; O Forslund; B Johansson; M von Knebel Doeberitz; C J Meijer; T Meyer; I Nindl; H Pfister; E Stockfleth; A Strand; G Wadell; J M Walboomers
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

9.  Distribution of HPV infection and tumour markers in cervical intraepithelial neoplasia from cone biopsies of Mozambican women.

Authors:  C Carrilho; L Cirnes; M Alberto; L Buane; N Mendes; L David
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

10.  Detection and quantitation of human papillomavirus by using the fluorescent 5' exonuclease assay.

Authors:  A Josefsson; K Livak; U Gyllensten
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.